孕晚期地诺前列酮栓引产的临床疗效及安全性:多中心回顾性分析
本文选题:地诺前列酮栓 + 缩宫素 ; 参考:《南方医科大学学报》2017年01期
【摘要】:目的大样本分析广东省珠三角地区5年中地诺前列酮栓用于孕晚期引产的临床疗效和安全性。方法将广东省珠三角地区使用地诺前列酮栓进行孕晚期引产的20家医院按医院级别分层,省级医院和市区级医院各选取三家医院作为研究单位。按照严格的纳入标准和剔除标准筛选出6家医院2010年1月~2014年12月1390例地诺前列酮栓引产病例作为研究组,并抽取同期957例单纯使用缩宫素引产病例作为对照组,回顾性分析地诺前列酮栓的临床疗效及安全性。结果地诺前列酮栓组的第1产程潜伏期时长为4.06±2.65 h,长于缩宫素组3.20±2.08 h,2组相比结果有统计学意义[P=0.003,95%CI(0.182,0.920)],地诺前列酮栓组活跃期及第2产程时长为1.73±1.32 h/0.49±0.37 h,短于缩宫素组2.22±1.75 h/0.54±0.43 h,两组相比结果有统计学意义[P=0.000,95%CI(-0.795,-0.363)/P=0.003,95%CI(-0.137,-0.028)],两组相比第1产程及总产程无统计学差异;两组经阴道分娩率无统计学差异;母婴不良反应发生率无统计学差异。结论孕晚期地诺前列酮栓引产的安全性与缩宫素相似,临床疗效优于缩宫素,是一种安全有效的引产方法。
[Abstract]:Objective to analyze the clinical efficacy and safety of 5-year Diloprostone suppository in late pregnancy induced labor in Pearl River Delta area of Guangdong Province. Methods Twenty hospitals in the Pearl River Delta area of Guangdong province were divided into hospital levels and three hospitals were selected as the research units for the induction of labor in the late pregnancy stage. The provincial hospitals and the urban hospitals respectively were selected as the research units. According to strict inclusion criteria and exclusion criteria, 1390 cases of induced labor induced by denoprostone suppository were selected from 6 hospitals from January 2010 to December 2014 as study group, and 957 cases of labor induced by oxytocin were selected as control group during the same period. The clinical efficacy and safety of dinoprostone suppository were analyzed retrospectively. Results the latency of the first stage of labor was 4.06 卤2.65 hours in the desitroprostone suppository group, which was significantly longer than that in the oxytocin group (3.20 卤2.08 h) [P < 0.003]. The active period and the second stage of labor were 1.73 卤1.32 h / 0.49 卤0.37 h, and 2.22 卤1.75 h respectively in the desnoprostone suppository group (P < 0.003), and the duration of the second stage of labor was 1.73 卤1.32 h / 0.49 卤0.37 h in the denoprostone suppository group, which was significantly longer than that in the oxytocin group (3.20 卤2.08 h). H / r 0.54 卤0.43 h, the results of the two groups were statistically significant (P < 0.000 ~ 95). There was no significant difference between the two groups in the first stage of labor and the total stage of labor. There was no significant difference in the rate of vaginal delivery between the two groups, and there was no significant difference in the incidence of adverse reactions between mother and infant. Conclusion the safety of diloprostone suppository is similar to oxytocin, and the clinical efficacy is better than oxytocin. It is a safe and effective method for induced labor.
【作者单位】: 南方医科大学南方医院妇产科;顺德第一人民医院妇产科;番禺何贤纪念医院妇产科;番禺中心医院妇产科;广州医科大学附属第三医院妇产科;中山大学孙逸仙纪念医院妇产科;
【基金】:广东省高等教育“创新强校工程”专项资金
【分类号】:R719.3
【相似文献】
相关期刊论文 前10条
1 颜志军;李艳;温雪萍;丁梅芬;;慢性阻塞性肺疾病患者血清环氧化酶-2和地诺前列酮浓度变化的临床意义[J];蚌埠医学院学报;2010年09期
2 厉跃红;;地诺前列酮栓与催生素用于妊娠足月引产的疗效观察[J];上海护理;2011年05期
3 李静波;郭玲;;控释地诺前列酮用于足月引产的疗效分析[J];实用临床医学;2007年06期
4 赵轶;国强;虞和永;杨波;;高效液相色谱法测定控释地诺前列酮栓含量的方法学考察[J];中国药学杂志;2009年08期
5 曾琴;李进;李咏梅;;控释地诺前列酮栓用于妊娠期糖尿病足月妊娠引产的疗效[J];中国妇产科临床杂志;2013年06期
6 刘继红;章小琴;梁丽涛;;地诺前列酮阴道栓剂用于分娩诱导的临床效果观察[J];现代妇产科进展;2008年06期
7 张焕潮;;地诺前列酮栓用于足月妊娠引产149例临床分析[J];中国厂矿医学;2009年06期
8 张莉莉;;地诺前列酮栓剂用于足月妊娠引产的临床观察[J];江苏医药;2012年21期
9 姜小庆;胡先华;;地诺前列酮栓与催产素对足月妊娠羊水偏少者引产的效果比较[J];中国现代医药杂志;2013年02期
10 姜小庆;胡先华;;计划分娩中地诺前列酮栓放置时间的选择[J];中国现代医药杂志;2013年07期
相关会议论文 前3条
1 陈姝;吴朝阳;吴为玲;;地诺前列酮用于足月妊娠计划分娩的疗效观察[A];第四届长三角妇产科学术论坛暨浙江省2009年妇产科学术年会论文汇编[C];2009年
2 周秋明;邬俊;邱静;;地诺前列酮栓剂用于足月妊娠引产的80例临床分析[A];第四届长三角妇产科学术论坛暨浙江省2009年妇产科学术年会论文汇编[C];2009年
3 王琳;居红芳;;地诺前列酮栓用于足月妊娠引产的临床观察[A];第四届长三角妇产科学术论坛暨浙江省2009年妇产科学术年会论文汇编[C];2009年
相关硕士学位论文 前3条
1 赵轶;控释地诺前列酮阴道栓用于过期妊娠引产的研究[D];浙江大学;2008年
2 苏梦;子宫颈扩张球囊与地诺前列酮栓及米索前列醇、低位小水囊在引产治疗中的应用与研究[D];山东大学;2014年
3 严春梅;米索前列醇与地诺前列酮用于足月妊娠引产比较的Meta分析[D];山东大学;2010年
,本文编号:1959282
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/1959282.html